1. Forming Effective Individualized Treatment Plans for Patients With Low-Risk MDS

3. Case 1

4. Etiology of Anemia

5. MDS Mutation Landscape

6. IPSS for MDS

7. The IPSS-R

8. WHO and WPSS Scoring System

9. MD Anderson Model of Prognosis for Patients With Low-Risk MDS

10. Case (cont)

11. Treat the Symptoms: Supportive Care

12. Case (cont)

13. Current "Standard" Therapy for MDS

14. Iron Chelation

15. Lenalidomide for Low-Risk MDS

16. Novel Agents: Siltuximab and Sotatercept

17. Case: Further Treatment Options

18. Hypomethylating Agents

19. Abbreviations

20. Abbreviations (cont)

21. References

22. References (cont)

23. References (cont)

24. References (cont)

25. References (cont)

26. References (cont)

27. References (cont)

28. References (cont)

29. References (cont)

30. References (cont)

31. References (cont)

32. References (cont)